Oxovanadium(IV) complexes of polypyridyl bases as photocytotoxic and DNA crosslinking agents

被引:0
作者
Kumar, Arun [1 ]
Dixit, Akanksha [2 ]
Banerjee, Samya [1 ]
Mukherjee, Sanjoy [1 ]
Sahoo, Somarupa [1 ]
Karande, Anjali A. [2 ]
Chakravarty, Akhil R. [1 ]
机构
[1] Indian Inst Sci, Dept Inorgan & Phys Chem, Bangalore 560012, Karnataka, India
[2] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India
来源
INDIAN JOURNAL OF CHEMISTRY SECTION A-INORGANIC BIO-INORGANIC PHYSICAL THEORETICAL & ANALYTICAL CHEMISTRY | 2018年 / 57卷 / 03期
关键词
Bioinorganic chemistry; Photocytotoxicity; Cytotoxicity; DNA crosslinks; DNA cleavage; Vanadium; Polypyridyl bases; CANCER; BINDING; CISPLATIN; SURVIVAL; THERAPY;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Dichlorooxovanadium(IV) complexes of polypyridyl bases (B), viz., [VO(B)Cl-2] (1 and 2) of N,N,N-donor ligands 2-(2-pyridy1)-1,10-phenanthroline (pyphen in 1) and 3-(pyridin-2-yDdipyrido[3,2-a:2',3'-c]phenazine (pydppz in 2) have been prepared, and their anticancer activity studied. The complexes show good solubility in most polar solvent and are non-electrolytes. They show 1:1 electrolytic property in 20% aqueous DMF, and 1:2 electrolytic character in 20% aqueous DMF upon photo-irradiation with visible light (400-700 nm). Complex 1 shows DNA crosslinking property on dissociation of the V-Cl bond(s) as ascertained from its DNA melting profile and ethidium bromide displacement assay. The complexes 1 and 2 are photocytotoxic towards HeLa (IC50: 16.9 mu M and 0.87 mu M respectively) and MCF-7 (IC50: 19.5 mu M and 1.4 mu M respectively) cancer cells, but exhibit less toxicity in normal embryonic fibroblast 3T3 cells with IC50 values of similar to 40 and similar to 25 mu M in visible light (400-700 nm) for complexes 1 and 2 respectively. Complex 2 also displays light induced plasmid DNA cleavage activity. The light-induced cellular damage leads to generation of reactive oxygen species followed by apoptotic cell death.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 37 条
  • [1] Photosensitizers in clinical PDT
    Allison, Ron R.
    Downie, Gordon H.
    Cuenca, Rosa
    Hu, Xin-Hua
    Childs, Carter J. H.
    Sibata, Claudio H.
    [J]. PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2004, 1 (01) : 27 - 42
  • [2] Photoinduced DNA Crosslink Formation by Dichloridooxidovanadium(IV) Complexes of Polypyridyl Bases
    Banerjee, Samya
    Dixit, Akanksha
    Kumar, Arun
    Mukherjee, Sanjoy
    Karande, Anjali A.
    Chakravarty, Akhil R.
    [J]. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2015, (24) : 3986 - 3990
  • [3] BEHRENS BC, 1987, CANCER RES, V47, P414
  • [4] A simple, high-resolution method for establishing DNA binding affinity and sequence selectivity
    Boger, DL
    Fink, BE
    Brunette, SR
    Tse, WC
    Hedrick, MP
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (25) : 5878 - 5891
  • [5] INTRASTRAND CROSS-LINKS ARE NOT FORMED IN THE REACTION BETWEEN TRANSPLATIN AND NATIVE DNA - RELATION WITH THE CLINICAL INEFFICIENCY OF TRANSPLATIN
    BOUDVILLAIN, M
    DALBIES, R
    AUSSOURD, C
    LENG, M
    [J]. NUCLEIC ACIDS RESEARCH, 1995, 23 (13) : 2381 - 2388
  • [6] VISCOSITY, NICKING, THERMAL AND ALKALINE DENATURATION STUDIES ON 3 CLASSES OF DNA-PLATINUM COMPLEX
    BUTOUR, JL
    MACQUET, JP
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 653 (03) : 305 - 315
  • [7] Synthesis, characterization, and assessment of cytotoxic properties of a series of titanocene dichloride derivatives
    Causey, PW
    Baird, MC
    Cole, SPC
    [J]. ORGANOMETALLICS, 2004, 23 (19) : 4486 - 4494
  • [8] A 1H NMR study of the DNA binding of ruthenium(II) polypyridyl complexes
    Collins, JG
    Sleeman, AD
    Aldrich-Wright, JR
    Greguric, I
    Hambley, TW
    [J]. INORGANIC CHEMISTRY, 1998, 37 (13) : 3133 - 3141
  • [9] DERIVATIVES OF 1,10-PHENANTHROLINE-5,6-QUINONE
    DICKESON, JE
    SUMMERS, LA
    [J]. AUSTRALIAN JOURNAL OF CHEMISTRY, 1970, 23 (05) : 1023 - &
  • [10] Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis
    Donnenberg, VS
    Donnenberg, AD
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (08) : 872 - 877